Retractable Technologies, Inc. Announces Dividends for Preferred Shareholders
Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) has recently made a significant announcement for its preferred stockholders. The Board of Directors has declared dividends amounting to $39,050.00 for the Series II Class B and $18,561.25 for Series III Class B Convertible Preferred Stock. This decision underscores Retractable's commitment to valuing its shareholders and ensuring they benefit from the company's success.
Details of the Dividend Payments
These dividends will be distributed based on an annual rate of $1.00 per share. This particular distribution covers the period from October 1, 2024, to December 31, 2024. For shareholders keen to know when these payments will be made, the dividends will be executed on January 20, 2025. It will be important for investors to note that only those on record as of January 10, 2025, will be eligible for this payment.
Overview of Retractable's Product Line
Retractable Technologies is well-known for its innovative medical products aimed at enhancing safety in healthcare environments. The company manufactures and markets a range of safety medical devices, including the VanishPoint and Patient Safe product lines, alongside the revolutionary EasyPoint needle.
VanishPoint Products
The VanishPoint syringe and associated products are specifically designed to mitigate the risks of needlestick injuries and ensure that needles retract safely post-use. This innovative technology is critical in reducing exposure to contaminated needles, which is a significant concern in healthcare settings.
Patient Safe Product Features
In addition to VanishPoint, Retractable's Patient Safe syringes play a crucial role in preventing bloodstream infections caused by catheter hub contamination. The design of these syringes enhances safety for medical personnel and patients alike, making Retractable a trusted name in medical safety equipment.
EasyPoint Needle: A Game-Changer in Medical Devices
The EasyPoint retractable needle represents a breakthrough in the field of syringe technology. This needle is adaptable for use with various syringes, such as luer lock syringes and prefilled syringes, making it versatile for different applications. It is not only efficient for administering injections but also effective for fluid aspiration and blood collection.
Distribution and Access to Retractable's Products
Retractable’s products are available through a wide array of specialty and general line distributors, ensuring that healthcare providers can easily access these essential safety products. With a focus on product reliability and safety, Retractable continues to expand its market presence.
Company Outlook and Future Projections
As Retractable Technologies continues to grow, its leadership remains optimistic about future opportunities. The company is dedicated to remaining at the forefront of innovation within the medical safety sector. While the announcement of dividends represents a strong position in terms of shareholder value, the focus on developing new and effective medical products remains a priority.
Frequently Asked Questions
What are the declared dividends for Retractable's preferred shareholders?
The declared dividends are $39,050.00 for Series II Class B and $18,561.25 for Series III Class B Convertible Preferred Stock.
When will these dividends be paid?
The dividends will be paid on January 20, 2025, to shareholders who are on record by the close of business on January 10, 2025.
What products does Retractable Technologies offer?
Retractable Technologies offers several safety medical products, including the VanishPoint syringes, Patient Safe syringes, and the EasyPoint retractable needle.
Why is Retractable's VanishPoint important?
The VanishPoint technology is crucial in preventing needlestick injuries, thereby enhancing safety for both medical staff and patients.
How can I learn more about Retractable Technologies?
For more detailed information about Retractable, please visit their official website at www.retractable.com.
